INsights & OUTcomes with Matt McLoughlin

episode

tHEORetically Speaking not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

More from tHEORetically Speaking

From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap 11 min · 13 Jul 2026

All episodes from tHEORetically Speaking →

Report any issue

Source

Recorded10 Jun 2025

Publisherfeeds.buzzsprout.com

Handlerec:11539527

Show notes

This episode features Matt McLoughlin, Senior Vice President of Compliance and Categories at Scientist.com. With 25 years in pharma R&D and Procurement, Matt has enhanced outsourcing for biopharma companies, focusing on speed, efficiency, and compliance. His expertise in regulated industries extends to RWE, HEOR, and Market Access, transforming access to external services to boost innovation while cutting costs and project timelines.To stay connected with us, visit our LinkedIn page and subscribe to our newsletter!Learn more about Scientist.com and how they can help with planning your book of work here: https://www.healtheconomics.com/5-key-questions-to-ask-before-you-launch-a-value-evidence-planHealth Economics is moving fast. From value frameworks to AI driven modeling, you don't want to miss what's next. Join thousands of professionals who trust Health Economics.com as their go to resource. Subscribe for weekly insights, expert commentary, and the latest developments across HEOR and market access: https://healtheconomics.com/subscribe/

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.